DePuy ASR Lawsuit New: Bernstein Liebhard LLP Notes Issuance of New Order Pertaining to DePuy ASR Hip Settlement

Share Article

The Firm is representing numerous plaintiffs in DePuy ASR lawsuits who are eligible to participate in the settlement program.

Free Case Review
We are pleased to see that matters pertaining to the DePuy ASR lawsuit settlement are moving forward, as we represent numerous plaintiffs who are eligible to participate in the program.

A new Order has been issued in the U.S. District Court, Northern District of Ohio that pertains to the DePuy ASR lawsuit ( settlement, Bernstein Liebhard LLP reports. According to the Order, which is dated June 4, 2014, the Court has established procedures governing the filing of motions to establish a qualified settlement fund for one or more plaintiffs on an individual firm basis. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“We are pleased to see that matters pertaining to the DePuy ASR lawsuit settlement are moving forward, as we represent numerous plaintiffs who are eligible to participate in the program,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who may have been harmed by metal-on-metal hip implants, including those devices which were part of the 2010 DePuy ASR recall.

DePuy ASR Recall
According to court documents, the DePuy ASR recall was announced in August 2010, after the metal-on-metal hip implants were found to be failing within just five years of implantation in an unacceptably high number of recipients. Since then, more than 12,000 ASR hip lawsuits have filed in U.S. courts, the majority of which are pending in the Northern District of Ohio. The DePuy ASR settlement agreement was announced by the Court in November 2013. Last month, Johnson & Johnson, the parent company of DePuy Orthopaedics, waived its “walk away rights” after a majority of eligible claimants agreed to accept the terms of the settlement, paving the way for the agreement to be finalized.

According to court records, plaintiffs qualified to participate in the DePuy ASR settlement include those who underwent revision surgery to replace their ASR hip due to a recall-related reason prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience "certain extraordinary injuries" in the future.

Court documents indicate that the DePuy ASR settlement program could resolve more than 8,000 product liability claims pending against Johnson & Johnson and DePuy. However, plaintiffs who do not wish to participate, or those who are not eligible, will still be permitted to pursue individual claims against the companies.

Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website